Fundraising Fox

Coya Therapeutics

NASDAQ: COYA

Houston, US · Founded 2020 · Delaware corporation · 1 known investors

coyatherapeutics.com ↗
Biotechin /coya-therapeutics@CoyaTx

Founders & leadership

DS
David SnyderExecutive Officer
FG
Fred GrossmanExecutive Officer
HB
Howard BermanExecutive Officer, Director
AG
Andrea GoldsteinExecutive Officer, Director
JT
Jani TuomiDirector
SM
Shawn M. TitcombDirector
DG
Dov GoldsteinDirector
WR
Wilbur RossDirector
HG
Hideki GarrenDirector
AV
Anabella VillalobosDirector
DW
Dieter WeinandDirector
AL
Ann LeeDirector

Investors · 1

Checkmate Capital Group LLCPasadena

Reported raises · per SEC filings

Form D private placements
▶$10MraisedOct 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SnyderExecutive Officer
  • Hideki GarrenDirector
  • Anabella VillalobosDirector
  • Dieter WeinandDirector
  • Ann LeeDirector
  • Fred GrossmanExecutive Officer
  • Dov GoldsteinDirector
  • Wilbur RossDirector
  • Howard BermanExecutive Officer, Director
  • Arun SwaminathanDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$700K
Placement agents
Wilmington Capital Securities, LLC, Chardan Capital Markets LLC, BTIG, LLC
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26.5MraisedDec 2023 · 122 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dieter WeinandDirector
  • Ann LeeDirector
  • Wilbur RossDirector
  • Fred GrossmanExecutive Officer
  • Howard BermanExecutive Officer, Director
  • Hideki GarrenDirector
  • Dov GoldsteinDirector
  • Anabella VillalobosDirector
  • David SnyderExecutive Officer
Offering amount
$26.5M
Amount sold
$26.5M
Placement agents
BTIG, LLC, Newbridge Securities Corporation
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.4MraisedMay 2022 · 45 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SnyderExecutive Officer
  • Anabella VillalobosDirector
  • Dov GoldsteinDirector
  • Adrian HepnerExecutive Officer
  • Ann LeeDirector
  • Howard BermanExecutive Officer, Director
  • Hideki GarrenDirector
  • Greg MacMichaelExecutive Officer
Offering amount
$20M
Amount sold
$10.4M
Sales commissions
$1.4M
Placement agents
Wilmington Capital Securities, LLC
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJan 2021 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard BermanExecutive Officer, Director
  • Andrea GoldsteinExecutive Officer, Director
  • Jani TuomiDirector
  • Shawn M. TitcombDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$700K
Placement agents
Shawn M. Titcomb
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.